STAGE I BLADDER CANCER AJCC V8
Clinical trials for STAGE I BLADDER CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE I BLADDER CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE I BLADDER CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New vaccine combo shows promise for tough bladder cancer
Disease control Recruiting nowThis early-stage trial tests a new vaccine (IO102-IO103) plus the immunotherapy drug pembrolizumab in 30 adults with a high-risk bladder cancer that did not respond to or could not tolerate standard BCG therapy. The vaccine aims to train the body's immune cells to recognize and a…
Matched conditions: STAGE I BLADDER CANCER AJCC V8
Phase: PHASE1 • Sponsor: University of California, Davis • Aim: Disease control
Last updated May 17, 2026 01:45 UTC
-
Immunotherapy may replace chemo in Bladder-Sparing cancer treatment
Disease control Recruiting nowThis study tests whether combining an immunotherapy drug (pembrolizumab) with radiation works better than standard chemotherapy plus radiation for people with a high-risk, early-stage bladder cancer that hasn't spread into the muscle. About 160 participants will receive either tr…
Matched conditions: STAGE I BLADDER CANCER AJCC V8
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Bladder cancer gets a targeted attack: new micelle therapy enters human trials
Disease control Recruiting nowThis early-stage trial tests a new treatment called PPM for people with a type of bladder cancer that has returned or not responded to standard therapy. PPM uses tiny particles (micelles) coated with a targeting molecule to deliver a chemotherapy drug directly to cancer cells in …
Matched conditions: STAGE I BLADDER CANCER AJCC V8
Phase: PHASE1 • Sponsor: University of California, Davis • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
New combo therapy aims to beat back bladder cancer recurrence
Disease control Recruiting nowThis phase 3 trial tests whether adding the chemotherapy drug gemcitabine to standard BCG immunotherapy can better prevent bladder cancer from coming back. About 330 people with recurrent high-grade non-muscle invasive bladder cancer will receive either BCG alone or BCG plus gemc…
Matched conditions: STAGE I BLADDER CANCER AJCC V8
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated May 11, 2026 20:41 UTC
-
Bladder cancer patients may soon get chemo at home
Symptom relief Recruiting nowThis study tests whether giving chemotherapy directly into the bladder at home is safe and works as well as in the clinic. About 40 adults with early-stage bladder cancer will receive their usual treatment at home. The goal is to see if home treatment is acceptable and less disru…
Matched conditions: STAGE I BLADDER CANCER AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated May 17, 2026 01:46 UTC
-
App-Based walking program aims to get bladder cancer patients moving
Symptom relief Recruiting nowThis study compares a home-based physical activity program delivered through the ExerciseRx app to standard health education in 100 adults with early-stage bladder cancer. Participants will use a Fitbit to track steps, and the app will set personalized goals and provide encourage…
Matched conditions: STAGE I BLADDER CANCER AJCC V8
Phase: NA • Sponsor: University of Washington • Aim: Symptom relief
Last updated May 06, 2026 16:01 UTC